Stock listing
HKEX:6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (科倫博泰生物) 股價
Home listing (HKEX) of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Follow Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Share price · HKEX:6990
$425.40 HKD +0.60 (+0.1%)
Close on Nov 2, 2026
- Day range
- $410.40 – $432.80 HKDNov 2, 2026
- Volume
- 749,350 sharesNov 2, 2026
- Market cap
- $75.22B HKDAt the close on Nov 2, 2026 · price × 176.8M shares outstanding
- 52-week range
- $339.60 – $562.50 HKDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $315.5M HKDMedian day 611,090 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:6990 · Home | $425.40 HKD | +0.60 (+0.1%) | 749,350 | $424.80 | $432.80 | $410.40 | $424.80 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · HKEX:6990 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $425.40 | +0.60 | +0.1% | $424.80 | $432.80 | $410.40 | 749,350 | |
| $424.80 | -13.00 | -3.0% | $445.00 | $451.00 | $422.40 | 697,959 | |
| $437.80 | +4.20 | +1.0% | $433.80 | $448.60 | $431.60 | 891,300 | |
| $433.60 | -19.60 | -4.3% | $451.60 | $461.20 | $432.40 | 1,200,975 | |
| $453.20 | -27.00 | -5.6% | $480.20 | $487.60 | $444.60 | 1,283,721 | |
| $480.20 | +19.80 | +4.3% | $470.00 | $499.80 | $466.20 | 1,723,000 | |
| $460.40 | +12.60 | +2.8% | $448.00 | $469.00 | $440.40 | 1,223,797 | |
| $447.80 | -25.40 | -5.4% | $464.80 | $479.20 | $443.80 | 776,249 | |
| $473.20 | +5.20 | +1.1% | $468.00 | $488.80 | $468.00 | 706,452 | |
| $468.00 | +16.00 | +3.5% | $458.00 | $473.00 | $448.00 | 709,561 | |
| $452.00 | +13.60 | +3.1% | $449.80 | $470.20 | $449.00 | 909,268 | |
| $438.40 | +1.20 | +0.3% | $437.00 | $452.60 | $433.20 | 518,550 | |
| $437.20 | -12.80 | -2.8% | $450.00 | $450.00 | $431.60 | 753,642 | |
| $450.00 | +0.20 | 0.0% | $438.00 | $451.40 | $436.60 | 339,529 | |
| $449.80 | +5.20 | +1.2% | $451.00 | $458.40 | $444.80 | 396,184 | |
| $444.60 | -1.20 | -0.3% | $459.40 | $459.40 | $430.20 | 678,100 | |
| $445.80 | -22.80 | -4.9% | $461.40 | $479.40 | $445.80 | 595,069 | |
| $468.60 | -9.40 | -2.0% | $476.40 | $476.40 | $459.40 | 118,074 | |
| $478.00 | +8.20 | +1.7% | $485.00 | $485.00 | $470.00 | 217,403 | |
| $469.80 | -2.40 | -0.5% | $489.00 | $489.00 | $462.60 | 133,890 | |
| $472.20 | -14.80 | -3.0% | $500.00 | $500.00 | $459.00 | 349,283 | |
| $487.00 | +14.00 | +3.0% | $465.20 | $497.80 | $465.20 | 852,603 | |
| $473.00 | +17.80 | +3.9% | $465.00 | $479.40 | $460.60 | 685,535 | |
| $455.20 | -11.80 | -2.5% | $476.00 | $476.00 | $451.60 | 454,540 | |
| $467.00 | +1.00 | +0.2% | $466.60 | $483.80 | $463.00 | 142,625 | |
| $466.00 | -17.00 | -3.5% | $483.80 | $483.80 | $463.40 | 344,671 | |
| $483.00 | -7.20 | -1.5% | $483.20 | $497.60 | $480.40 | 392,527 | |
| $490.20 | -5.40 | -1.1% | $495.60 | $499.80 | $483.00 | 647,020 | |
| $495.60 | +34.00 | +7.4% | $475.40 | $502.00 | $472.20 | 1,579,561 | |
| $461.60 | +0.20 | 0.0% | $471.00 | $472.80 | $453.60 | 1,320,182 | |
| $461.40 | +0.80 | +0.2% | $455.00 | $467.60 | $450.00 | 479,502 | |
| $460.60 | -1.80 | -0.4% | $466.20 | $471.00 | $456.00 | 682,604 | |
| $462.40 | -18.80 | -3.9% | $481.20 | $487.60 | $456.20 | 699,464 | |
| $481.20 | +16.00 | +3.4% | $451.00 | $485.60 | $451.00 | 852,402 | |
| $465.20 | -9.20 | -1.9% | $465.20 | $473.80 | $459.80 | 656,359 | |
| $474.40 | -6.60 | -1.4% | $481.00 | $481.60 | $467.40 | 736,288 | |
| $481.00 | -7.00 | -1.4% | $488.00 | $494.00 | $478.40 | 485,320 | |
| $488.00 | -2.40 | -0.5% | $483.00 | $494.60 | $478.60 | 311,400 | |
| $490.40 | +1.00 | +0.2% | $498.40 | $498.40 | $483.00 | 255,116 | |
| $489.40 | -7.40 | -1.5% | $505.00 | $509.50 | $486.80 | 469,400 | |
| $496.80 | +3.80 | +0.8% | $489.00 | $504.00 | $489.00 | 451,756 | |
| $493.00 | +3.20 | +0.7% | $480.20 | $499.60 | $480.20 | 463,511 | |
| $489.80 | -7.40 | -1.5% | $490.00 | $504.50 | $478.00 | 588,672 | |
| $497.20 | -17.30 | -3.4% | $493.60 | $507.00 | $485.20 | 1,232,718 | |
| $514.50 | -10.00 | -1.9% | $527.00 | $531.00 | $508.00 | 681,705 | |
| $524.50 | +4.00 | +0.8% | $530.00 | $535.50 | $515.00 | 605,700 | |
| $520.50 | -3.00 | -0.6% | $535.00 | $542.50 | $517.00 | 709,172 | |
| $523.50 | +0.50 | +0.1% | $543.00 | $543.00 | $511.50 | 498,706 | |
| $523.00 | -15.00 | -2.8% | $540.00 | $543.00 | $516.50 | 545,535 | |
| $538.00 | +5.00 | +0.9% | $541.50 | $545.00 | $527.50 | 561,824 | |
| $533.00 | +9.50 | +1.8% | $540.50 | $562.50 | $525.50 | 1,574,283 | |
| $523.50 | -19.00 | -3.5% | $530.00 | $548.00 | $518.00 | 473,584 | |
| $542.50 | +20.00 | +3.8% | $530.50 | $546.50 | $517.50 | 650,430 | |
| $522.50 | +2.00 | +0.4% | $513.00 | $531.00 | $509.00 | 421,905 | |
| $520.50 | -5.00 | -1.0% | $528.50 | $528.50 | $511.00 | 403,100 | |
| $525.50 | -3.00 | -0.6% | $536.50 | $538.50 | $520.00 | 594,787 | |
| $528.50 | 0.00 | 0.0% | $519.00 | $537.50 | $519.00 | 303,900 | |
| $528.50 | 0.00 | 0.0% | $538.50 | $540.00 | $521.00 | 616,480 | |
| $528.50 | -11.00 | -2.0% | $539.50 | $552.00 | $523.00 | 604,755 | |
| $539.50 | +31.50 | +6.2% | $499.40 | $541.00 | $499.40 | 741,005 | |
| $508.00 | +16.20 | +3.3% | $480.00 | $519.00 | $480.00 | 618,201 | |
| $491.80 | +10.00 | +2.1% | $472.00 | $505.00 | $472.00 | 412,885 | |
| $481.80 | +5.00 | +1.0% | $488.80 | $490.80 | $476.20 | 368,705 | |
| $476.80 | -7.00 | -1.4% | $483.80 | $494.80 | $461.40 | 771,136 |
- Ticker
- HKEX:6990
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news
Voluntary announcement new indication application for core product TROP2 ADC sacituzumab tirumotecan (sac-TMT) accepted by the national medical products administration
Oct 27, 2026
Closed $433.60 (-4.3%) on Oct 28, 2026
Voluntary announcement results from multiple studies of innovative drugs at 2026 ESMO congress
Oct 25, 2026
Closed $480.20 (+4.3%) on Oct 26, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 2, 2026
Closed $469.80 (-0.5%) on Oct 5, 2026
Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session
Sep 22, 2026
Closed $490.20 (-1.1%) on Sep 22, 2026
2026 Interim report
Sep 17, 2026
Closed $461.60 (0.0%) on Sep 18, 2026
Results from Phase III Study of Trastuzumab Botidotin versus T-DM1 in HER2-Positive Breast Cancer Published in JCO
Sep 14, 2026
Closed $481.20 (+3.4%) on Sep 14, 2026
Kelun-Biotech Announces 2026 Interim Results
Aug 17, 2026
Closed $542.50 (+3.8%) on Aug 18, 2026
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
Jul 30, 2026
Closed $483.80 (+0.6%) on Jul 31, 2026
Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565
Jul 27, 2026
Closed $508.50 (-1.0%) on Jul 28, 2026
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma
Jul 15, 2026
Closed $522.50 (-2.6%) on Jul 16, 2026
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 52 in all · newest Oct 27, 2026 · oldest 2025
Where Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:6990 科倫博泰生物 · Home listing · This page | HKEX | Hong Kong | HKD |
| OTC:SKBBY | OTC | United States | USD |
Log in to ask 6ix AI your own questions about Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.